Citius Oncology (CTOR) Financial Statements & Analysis

Citius Oncology Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Citius Oncology, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022
Period ending	Sep 2025	Sep 2024	Sep 2023	Sep 2022
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	6.42	4.93	4.24	3.43
Selling, General & Administrative	17.10	15.65	7.88	1.43
Operating Expenses	23.52	20.57	12.12	4.86
Operating Income	-23.52	-20.57	-12.12	-4.86
Other Income/Expense
Interest Income	0.04	0.00	3.43	0.49
Interest Expense	0.22	0.00	0.00	0.00
Other Income/Expense	-0.18	0.00	0.00	0.52
Income
Income Before Tax	-23.70	-20.57	-12.12	-4.86
Income Tax Expense	1.06	0.58	0.58	0.58
Net Income	-24.76	-21.15	-12.70	-5.43
Net Income - Continuous Operations	-24.76	-21.15	-12.70	-5.43
Net Income - Discontinued Operations	-	-	-	-
EBITDA	-23.49	-20.57	-12.12	-4.86
EBIT	-23.52	-20.57	-12.12	-4.86
Depreciation & Amortization	0.00	0.00	0.00	9.71
Earnings Per Share
Basic EPS	-	-	-	-
Diluted EPS	-	-	-	-
Basic Shares Outstanding	73.27	68.05	67.50	71.24
Diluted Shares Outstanding	73.27	68.05	67.50	71.24

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Citius Oncology Financial Statements

Is Citius Oncology profitable?

No. Citius Oncology reported a net loss of $24.76M in fiscal 2025. In fiscal 2024 it lost $21.15M.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition